Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-01-16Clinical Trial Update: The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL [NA]
A clinical trial evaluating the effects of teriparatide on vascular function and the OPG/RANKL pathway in osteoporosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-10Clinical Trial Update: What is the Best Policy to Prevent Osteoporotic Fracture? [NA]
A clinical trial examining policies to prevent osteoporotic fracture was withdrawn, with no results reported.
-
CLINICAL_TRIALS withdrawal · 2012-11-29Clinical Trial Update: Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS [Phase 3]
A Phase 3 trial evaluating risedronate to improve bone mineral density in postmenopausal women with ductal carcinoma in situ has been withdr…
-
EMA withdrawal · 2012-06-21EMA Lapsed: Fablyn (Lasofoxifene tartrate) — Dr. Friedrich Eberth Arzneimittel GmbH
EMA indicates the marketing authorization for Fablyn (lasofoxifene tartrate) has lapsed, primarily in the osteoporosis/postmenopausal settin…
-
CLINICAL_TRIALS withdrawal · 2012-02-03Clinical Trial Update: An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness
An open clinical trial investigating the influence of aminobiphosphonates on arterial stiffness has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2011-08-22EMA Application withdrawn: Ibandronic Acid Hexal (ibandronic acid) — Hexal AG
The EMA withdrew the application for Ibandronic Acid Hexal (ibandronic acid) from the market. Therapeutic areas listed include hypercalcemia…
-
CLINICAL_TRIALS withdrawal · 2008-03-13Clinical Trial Update: Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD [Phase 2]
Phase 2 clinical trial evaluating intranasal teriparatide to improve bone mineral density in postmenopausal women with low bone density has …